complex generics Archives - Express Pharma

DoP implements PLI scheme for pharmaceuticals with a financial outlay of Rs 15,000 cr

Credit profile of Indian pharma cos to remain healthy in FY2025 despite moderation in revenue growth: ICRA

Pharma industry headwinds in remission: ICRA

Stability of input costs, specialty product launches to support performance of Indian pharma companies in FY2024: ICRA

The (pharma) sector is learning to create capabilities in innovative R&D rapidly

Amneal completes acquisition of Kashiv Specialty Pharmaceuticals

Innovation – The next frontier

Slayback Pharma announces investment of $50 million by The Everstone Group